Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

BiondVax Pharmaceuticals Ltd. (BVXV)

2.6   0.01 (0.39%) 02-02 15:18
Open: 2.55 Pre. Close: 2.59
High: 2.6497 Low: 2.545
Volume: 68,943 Market Cap: 5(M)

Technical analysis

as of: 2023-02-02 3:10:20 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.65     One year: 4.2
Support: Support1: 2.36    Support2: 1.97
Resistance: Resistance1: 3.13    Resistance2: 3.59
Pivot: 2.71
Moving Average: MA(5): 2.6     MA(20): 2.74
MA(100): 6.75     MA(250): 10.36
MACD: MACD(12,26): -0.7     Signal(9): -0.9
Stochastic oscillator: %K(14,3): 32.7     %D(3): 30.7
RSI: RSI(14): 31.1
52-week: High: 22.89  Low: 1.14
Average Vol(K): 3-Month: 162 (K)  10-Days: 152 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ BVXV ] has closed above bottom band by 29.6%. Bollinger Bands are 86.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.65 - 2.67 2.67 - 2.68
Low: 2.49 - 2.51 2.51 - 2.52
Close: 2.56 - 2.59 2.59 - 2.61

Company Description

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Headline News

Thu, 02 Feb 2023
BiondVax Presenting at BIO CEO & Investor Conference - The Bakersfield Californian

Thu, 02 Feb 2023
BiondVax Presenting at BIO CEO & Investor Conference - BiondVax Pharmaceuticals (NASDAQ:BVXV) - Benzinga

Wed, 01 Feb 2023
BiondVax Pharmaceuticals (NASDAQ:BVXV) Now Covered by ... - Armenian Reporter

Tue, 31 Jan 2023
Is Biondvax Pharmaceuticals Ltd - ADR (BVXV) a Winner in the Biotechnology Industry? - InvestorsObserver

Mon, 30 Jan 2023
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Reports ... -

Fri, 27 Jan 2023
Do Traders Think Biondvax Pharmaceuticals Ltd - ADR (BVXV) Can Turn Around Friday? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 2 (M)
Shares Float 1 (M)
% Held by Insiders 27.7 (%)
% Held by Institutions 13.2 (%)
Shares Short 56 (K)
Shares Short P.Month 38 (K)

Stock Financials

EPS -2.3
EPS Est Next Qtl 0
EPS Est This Year -0.02
EPS Est Next Year -0.02
Book Value (p.s.) 0.61
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -21
Return on Equity (ttm) -432.3
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -1.14
PEG Ratio 0
Price to Book value 4.28
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.